Welcome to our dedicated page for Dogecoin Cash news (Ticker: CBDS), a resource for investors and traders seeking the latest updates and insights on Dogecoin Cash stock.
Dogecoin Cash Inc. (CBDS) generates news at the intersection of medical cannabis telemedicine, cannabis intellectual property, and blockchain-focused digital asset initiatives. Company announcements highlight developments across its PrestoDoctor telehealth operations, cannabis product and strain patents, and projects related to Dogecoin and meme-based tokens.
News items often cover PrestoDoctor’s expansion into additional U.S. states for medical cannabis evaluations, updates on telehealth services, and platform capabilities designed for compliance with state medical cannabis and telemedicine rules. These releases provide insight into how the company grows its medical cannabis telehealth footprint and adapts its technology to regulated healthcare environments.
Dogecoin Cash Inc. also issues news about its cannabis product development and licensing activities, including references to its patented cannabis strain Ecuadorian Sativa ("CTA") and its patented cannabis lozenge for hypertension. Such disclosures help readers understand the company’s role in cannabis genetics and dosage-form innovation.
On the blockchain side, the company publishes updates on digital asset initiatives, including the formation of Dogecoin Treasury, Inc., work on the proposed Dogecoin Protocol, and activities within MEME Coins Inc. related to DOG tokens and meme-based cryptocurrency concepts. These news releases describe patent filings, technical frameworks, and digital asset strategies involving Dogecoin and related tools.
Investors and observers can use this news feed to follow how Dogecoin Cash Inc. develops its telehealth platform, advances its cannabis IP portfolio, and pursues blockchain and digital asset projects. Regularly reviewing CBDS news can provide context on the company’s evolving mix of cannabis and blockchain-focused activities.
Cannabis Sativa (OTCQB:CBDS) announced that its Brand Ambassador, Randy Lanier, is featured in Netflix's "Need for Weed", part of the "Bad Sport" docuseries. The episode highlights Lanier's dual career as a race car driver and cannabis importer, detailing his achievements, including the 1984 IMSA Championship and Rookie of the Year at the 1986 Indianapolis 500. Lanier now supports cannabis prisoners via Freedom Grow. CEO David Tobias emphasizes the public’s growing acceptance of cannabis legalization, stating that the docuseries tells a critical story in cannabis history.
Cannabis Sativa, Inc. (OTCQB:CBDS) announced that PrestoDoctor will be a Diamond Sponsor at the Pennsylvania Cannabis Fall Marketplace on October 2 & 3. The event will be held at Renninger's Farmers Market in Kutztown, featuring free admission and over 50 vendors. PrestoDoctor will provide on-site medical evaluations, utilizing their proprietary technology for efficient sign-ups. As a top-rated online cannabis recommendation service, PrestoDoctor has earned over 17,000 five-star reviews and has helped thousands of patients obtain medical cannabis cards across several states.
Cannabis Sativa (OTCQB:CBDS) has launched Cannabis Sativa Magazine, a new digital news platform focusing on cannabis and hemp industry insights. The magazine aims to cover a variety of topics including investor news, politics, lifestyle, and health. CEO David Tobias emphasized that this new domain enhances their intellectual property portfolio. The company continues to explore direct cannabis involvement through innovations in a patented cannabis strain and aims for vertical integration in the industry to improve control over supply chains and product quality.
Cannabis Sativa, Inc. (OTCQB:CBDS) has signed a Term Sheet to acquire Stratum Brands, a cannabis product manufacturer based in Los Angeles, with a 2020 revenue of $2.8 million. Stratum offers various product lines, including Cobra Extracts and LA Kingpins vapes, distributed across over 50 California dispensaries. The acquisition will involve issuing stock valued at $1.715 million for 49% ownership, with an option for further investment post-audit. This strategic move aims to enhance Cannabis Sativa's manufacturing and distribution capabilities.
Cannabis Sativa, Inc. (OTCQB:CBDS) reported Q1 2021 revenues of $557,323, with its subsidiary PrestoDoctor contributing $482,350 and achieving a margin of 62%. This represents a 13% growth compared to Q1 2020. Management anticipates further growth driven by PrestoDoctor’s expansion into newly legalized states for medical marijuana and effective advertising campaigns in Oklahoma and Iowa. The company aims to enhance its presence in the cannabis market through vertical integration, including cultivating its unique cannabis strain and acquiring dispensaries.
Cannabis Sativa, Inc. (OTCQB:CBDS) reported a 75% increase in revenue for the fiscal year ending December 31, 2020, reaching $2,035,383, compared to $1,159,737 in 2019. This growth is attributed to its 51% owned subsidiary PrestoCorp, which benefited from the surge in telemedicine demand due to COVID-19. However, its other subsidiary, GK Manufacturing and Packaging, reported lower revenues of $94,552 and a cost of revenues of $152,837. The company has invested $750,000 in GKMP, which is facing delays in operations.
Cannabis Sativa, Inc. (OTCQB:CBDS) announced that PrestoDoctor will conduct on-site medical evaluations at the Pennsylvania Cannabis Festival on April 17-18. This festival, featuring free admission, leads up to the popular cannabis celebration on 4/20. PrestoDoctor, known for its telemedicine services, has completed over 100 in-person events. The service allows attendees to quickly complete their medical evaluations without traditional clinic visits. PrestoDoctor has received over 15,000 five-star reviews, indicating strong customer satisfaction.
Cannabis Sativa, Inc. (CBDS) announced that its telemedicine service, PrestoDoctor, will host an online event titled Missouri Dispensary 101 on March 13, 2021. The event aims to educate attendees about the Missouri medical cannabis program, available dispensaries, and the process for acquiring medical cannabis cards. Participants will receive a discount code post-event. PrestoDoctor is known for its patient-rated services and has assisted thousands in obtaining medical cannabis cards across several states, including Missouri.
Cannabis Sativa, Inc. (OTCQB:CBDS) announces the expansion of PrestoDoctor, a leading telemedicine service for medical cannabis, into Iowa. Established in 2015, PrestoDoctor has served over 100,000 patients across seven states. CEO David Tobias highlighted that Iowa marks a new market expected to yield significant revenue growth, driven by increasing medical cannabis demand. PrestoDoctor is HIPAA compliant and offers personalized treatment plans, building on its reputation as the top-rated online medical marijuana doctor service with nearly 15,000 five-star reviews.
Cannabis Sativa, Inc. (OTCQB:CBDS) announces that PrestoDoctor's Rob Tankson is featured in Forbes Next 1000 Upstart Entrepreneurs, highlighting innovative business leaders. PrestoDoctor, acquired by Cannabis Sativa in 2017 for $9 million, connects 185,000 patients with licensed physicians for medical cannabis recommendations. The telemedicine platform serves multiple states and aims for expansion. With secure video technology, PrestoDoctor ensures patient confidentiality and convenience. It holds a high satisfaction rating with over 14,850 5-star reviews.